delamanid
Selected indexed studies
- Delamanid. (, 2006) [PMID:38913818]
- Delamanid Resistance: Update and Clinical Management. (Clin Infect Dis, 2020) [PMID:32521000]
- Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis. (Int J Infect Dis, 2022) [PMID:35245659]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician's perspective. (2020) pubmed
- Delamanid. (2006) pubmed
- Delamanid Resistance: Update and Clinical Management. (2020) pubmed
- Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis. (2022) pubmed
- Delamanid: first global approval. (2014) pubmed
- Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB). (2018) pubmed
- [Expert consensus on clinical application of delamanid]. (2022) pubmed
- Delamanid in the treatment of multidrug-resistant tuberculosis. (2016) pubmed
- Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging. (2019) pubmed
- Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial. (2025) pubmed